Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dapagliflozin”

521 trials

Showing 20 of 521 results

Large-scale testing (Phase 3)Study completedNCT02518945
What this trial is testing

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University at Buffalo 26
Not applicableStudy completedNCT06778330
What this trial is testing

The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension

Who this might be right for
Heart Failure NYHA Class II
Fayoum University 100
Post-approval studies (Phase 4)Study completedNCT02956811
What this trial is testing

Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?

Who this might be right for
Type 2 DiabetesLeft Ventricular Hypertrophy
University of Dundee 66
Post-approval studies (Phase 4)Study completedNCT06026787
What this trial is testing

Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeSodium-Glucose Transporter 2 Inhibitors
Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT06012279
What this trial is testing

Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)

Who this might be right for
Acute Heart Failure
Cairo University 117
Not applicableStudy completedNCT04240171
What this trial is testing

Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Damanhour University 60
Post-approval studies (Phase 4)UnknownNCT05915949
What this trial is testing

Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety

Who this might be right for
Diabetes Type 2
Seoul National University Bundang Hospital 99
Large-scale testing (Phase 3)Study completedNCT00859898
What this trial is testing

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,093
Testing effectiveness (Phase 2)UnknownNCT04258371
What this trial is testing

DAPAgliflozin Sodium Water glucosE EffecTs in Patients at High Cardiovascular Risk

Who this might be right for
Cardiovascular Risk Factor
University Health Network, Toronto 50
Early research (Phase 1)Ended earlyNCT04234867
What this trial is testing

Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)

Who this might be right for
Type 1 DiabetesDiabetic Ketoacidosis
Kinderkrankenhaus auf der Bult 2
Early research (Phase 1)Study completedNCT02722239
What this trial is testing

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 40
Not applicableNot Yet RecruitingNCT06510270
What this trial is testing

Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction

Who this might be right for
Heart Failure with Preserved Ejection Fraction
Aswan University 70
Not applicableUnknownNCT05759000
What this trial is testing

Dapa Acute Heart Failure Study

Who this might be right for
Heart Failure
Chinese University of Hong Kong 100
Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Large-scale testing (Phase 3)UnknownNCT04860011
What this trial is testing

DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance

Who this might be right for
Heart Failure
NHS Greater Glasgow and Clyde 61
Testing effectiveness (Phase 2)Looking for participantsNCT06942910
What this trial is testing

Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Who this might be right for
Chronic Kidney Disease With High Proteinuria
AstraZeneca 224
Testing effectiveness (Phase 2)Study completedNCT06350123
What this trial is testing

Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
AstraZeneca 324
Post-approval studies (Phase 4)Study completedNCT03499704
What this trial is testing

Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Celltrion Pharm, Inc. 133
Early research (Phase 1)Study completedNCT05403281
What this trial is testing

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation